J Seldrup

781 total citations
34 papers, 583 citations indexed

About

J Seldrup is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Statistics and Probability. According to data from OpenAlex, J Seldrup has authored 34 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Statistics and Probability. Recurrent topics in J Seldrup's work include Statistical Methods in Clinical Trials (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Epilepsy research and treatment (4 papers). J Seldrup is often cited by papers focused on Statistical Methods in Clinical Trials (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Epilepsy research and treatment (4 papers). J Seldrup collaborates with scholars based in United Kingdom, Switzerland and France. J Seldrup's co-authors include Stuart Pocock, G Beaumont, Venkataraman Anantharaman, Siew Tiang Lau, Marcus Eng Hock Ong, Yiong Huak Chan, Swee Han Lim, Bee‐Choo Tai, David Machin and Myung‐Jin Kim and has published in prestigious journals such as PEDIATRICS, The British Journal of Psychiatry and Statistics in Medicine.

In The Last Decade

J Seldrup

31 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Seldrup United Kingdom	12	90	84	82	65	65	34	583
John P. Morgan United States	16	44 0.5×	51 0.6×	103 1.3×	151 2.3×	28 0.4×	39	840
Mark Donaldson United States	17	35 0.4×	78 0.9×	62 0.8×	70 1.1×	75 1.2×	75	1.1k
Michael Gordon Canada	15	102 1.1×	171 2.0×	27 0.3×	10 0.2×	43 0.7×	41	699
Barbara Genovese United States	9	16 0.2×	80 1.0×	138 1.7×	27 0.4×	13 0.2×	14	622
Karen Hall United States	16	21 0.2×	60 0.7×	43 0.5×	14 0.2×	40 0.6×	52	980
Montserrat Martín‐Baranera Spain	17	44 0.5×	40 0.5×	23 0.3×	10 0.2×	35 0.5×	83	848
Andrew Dentino United States	10	31 0.3×	72 0.9×	33 0.4×	33 0.5×	6 0.1×	36	658
KS Channer United Kingdom	18	85 0.9×	77 0.9×	129 1.6×	4 0.1×	42 0.6×	48	1.4k
Amol Deshpande Canada	11	45 0.5×	57 0.7×	517 6.3×	73 1.1×	28 0.4×	26	940
Richard V. Sims United States	16	26 0.3×	94 1.1×	30 0.4×	4 0.1×	36 0.6×	25	1.3k

Countries citing papers authored by J Seldrup

Since Specialization

Citations

This map shows the geographic impact of J Seldrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Seldrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Seldrup more than expected).

Fields of papers citing papers by J Seldrup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Seldrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Seldrup. The network helps show where J Seldrup may publish in the future.

Co-authorship network of co-authors of J Seldrup

This figure shows the co-authorship network connecting the top 25 collaborators of J Seldrup. A scholar is included among the top collaborators of J Seldrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Seldrup. J Seldrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seldrup, J. (2011). Regulatory advice and drug development—A case study in negotiating with regulators. Statistics in Medicine. 30(13). 1628–1635. 3 indexed citations

O’Kelly, Michael, Steven A. Julious, Stephen Pyke, et al.. (2010). Making available information from studies sponsored by the pharmaceutical industry: some current practices. Pharmaceutical Statistics. 10(1). 60–69. 6 indexed citations

Pyke, Stephen, Steven A. Julious, Simon Day, et al.. (2010). The potential for bias in reporting of industry‐sponsored clinical trials. Pharmaceutical Statistics. 10(1). 74–79. 13 indexed citations

Matcham, James, Steven A. Julious, Stephen Pyke, et al.. (2010). Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry‐sponsored clinical trials. Pharmaceutical Statistics. 10(1). 70–73. 13 indexed citations

Callaghan, N., M. Feely, Michael O’Callaghan, et al.. (2009). THE EFFECTS OF TOXIC AND NON-TOXIC SERUM PHENYTOIN LEVELS ON CARBOHYDRATE TOLERANCE AND INSULIN LEVELS. Acta Neurologica Scandinavica. 56(6). 563–571. 2 indexed citations

Goh, Boon Tong, et al.. (2006). A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 102(1). 47–55. 70 indexed citations

Vathsala, Anantharaman, et al.. (2004). SAFETY AND EFFICACY OF CAMPATH-1H (MABCAMPATH®) WITH LOW DOSE CYCLOSPORINE MONOTHERAPY IN PATIENTS RECEIVING KIDNEY TRANSPLANTS- 6 MONTH ANALYSIS OF THE PILOT RANDOMISED CONTROLLED TRIAL. Transplantation. 78. 56–56. 4 indexed citations

Ong, Marcus Eng Hock, Yiong Huak Chan, Venkataraman Anantharaman, et al.. (2003). C ARDIAC A RREST AND R ESUSCITATION E PIDEMIOLOGY IN S INGAPORE (CARE I S TUDY ). Prehospital Emergency Care. 7(4). 427–433. 63 indexed citations

Tai, Bee‐Choo & J Seldrup. (2000). A Review of Software for Data Management, Design and Analysis of Clinical Trials. Annals of the Academy of Medicine Singapore. 29(5). 576–576. 14 indexed citations

10.

Beaumont, G & J Seldrup. (1980). Comparative trial of clomipramine and placebo in the treatment of terminal pain.. PubMed. 8 Suppl 3. 67–9. 6 indexed citations

11.

Seldrup, J. (1980). Relating plasma levels of clomipramine and clinical response.. PubMed. 8 Suppl 3. 96–110. 1 indexed citations

12.

Aylward, Mansel, P D Fowler, V. A. John, J. Maddock, & J Seldrup. (1979). The influence of diclofenac sodium (Voltarol) on free, protein-bound and total plasma L-tryptophan in adult healthy male subjects.. ORCA Online Research @Cardiff (Cardiff University). Suppl 2. 47–59. 5 indexed citations

13.

Duggan, B., et al.. (1979). The therapeutic range for phenytoin — A reappraisal. Irish Journal of Medical Science (1971 -). 148(1). 44–49. 8 indexed citations

14.

Beaumont, G, et al.. (1977). A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.. PubMed. 5(1 Suppl). 119–24. 4 indexed citations

15.

Beaumont, G, et al.. (1977). An Evaluation of Andursil – A New Antacid. Journal of International Medical Research. 5(6). 99–104. 27 indexed citations

16.

Beaumont, G, et al.. (1977). Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).. PubMed. 5 Suppl 4. 101–11. 7 indexed citations

17.

Seldrup, J, et al.. (1977). Obsessional states. Acta Psychiatrica Scandinavica. 56(5). 427–431. 38 indexed citations

18.

Link, Jenny C., et al.. (1976). Plasma prolactin concentrations in patients on clomipramine.. PubMed. 52(3 suppl). 93–102. 15 indexed citations

19.

Maxwell, Cynthia & J Seldrup. (1971). Factors relating to the optimum effect of imipramine in the treatment of enuresis.. PubMed. 21(9). 1352–6. 4 indexed citations

20.

Maxwell, Cynthia & J Seldrup. (1971). General practitioners' forum. Imipramine in the treatment of childhood enuresis.. PubMed. 207(242). 809–14. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact